Therefore, the present study aimed to investigate the biological effect of the selective PERK inhibitor NCI 159456 on A549 NSCLC cells and Human Pulmonary Fibroblasts (HPF) in vitro. The gene discussed is EIF2AK3; the disease is non-small cell lung carcinoma.